Pascal Espié

1.0k total citations
21 papers, 625 citations indexed

About

Pascal Espié is a scholar working on Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Pascal Espié has authored 21 papers receiving a total of 625 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Immunology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Pascal Espié's work include Mitochondrial Function and Pathology (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and T-cell and B-cell Immunology (4 papers). Pascal Espié is often cited by papers focused on Mitochondrial Function and Pathology (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and T-cell and B-cell Immunology (4 papers). Pascal Espié collaborates with scholars based in Switzerland, France and United States. Pascal Espié's co-authors include Armel Stockis, Jean‐Marie Nicolas, Maria Laura Sargentini‐Maier, Alain Coquette, Mathiéu Molimard, D. Tytgat, Jean‐Baptiste Watelet, Italo Poggesi, James S. Rush and Michel Rigoulet and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Annals of the Rheumatic Diseases and Transplantation.

In The Last Decade

Pascal Espié

20 papers receiving 610 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pascal Espié Switzerland 12 135 111 108 106 92 21 625
Kyoko Matsuguma Japan 12 86 0.6× 39 0.4× 54 0.5× 115 1.1× 76 0.8× 16 636
Himanshu Naik United States 14 40 0.3× 210 1.9× 56 0.5× 176 1.7× 101 1.1× 37 748
Haiqing Dai United States 11 135 1.0× 70 0.6× 43 0.4× 129 1.2× 343 3.7× 24 714
Christodoulos Flordellis Greece 17 56 0.4× 60 0.5× 40 0.4× 368 3.5× 74 0.8× 45 883
Megan Kane United States 11 69 0.5× 42 0.4× 64 0.6× 259 2.4× 85 0.9× 28 660
Tomoaki Higuchi Japan 13 105 0.8× 41 0.4× 25 0.2× 155 1.5× 221 2.4× 44 526
Michael Heathman United States 12 41 0.3× 45 0.4× 54 0.5× 170 1.6× 135 1.5× 24 604
Kevin Dykstra United States 12 70 0.5× 39 0.4× 43 0.4× 95 0.9× 92 1.0× 23 523
Gordon Loewen United States 13 55 0.4× 57 0.5× 48 0.4× 381 3.6× 140 1.5× 38 861

Countries citing papers authored by Pascal Espié

Since Specialization
Citations

This map shows the geographic impact of Pascal Espié's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal Espié with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal Espié more than expected).

Fields of papers citing papers by Pascal Espié

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pascal Espié. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal Espié. The network helps show where Pascal Espié may publish in the future.

Co-authorship network of co-authors of Pascal Espié

This figure shows the co-authorship network connecting the top 25 collaborators of Pascal Espié. A scholar is included among the top collaborators of Pascal Espié based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pascal Espié. Pascal Espié is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Flandre, Thierry, Keith G. Mansfield, Pascal Espié, Tina Rubic-Schneider, & Peter Ulrich. (2022). Immunosuppression Profile of CFZ533 (Iscalimab), a Non-Depleting Anti-CD40 Antibody, and the Presence of Opportunistic Infections in a Rhesus Monkey Toxicology Study. Toxicologic Pathology. 50(5). 712–724. 4 indexed citations
2.
Kaul, Martin, Philip Jarvis, Izabela Rozenberg, et al.. (2020). First‐in‐human study demonstrating the safety and clinical efficacy of novel anti‐IL‐17A monoclonal antibody CJM112 in moderate to severe plaque psoriasis. Journal of the European Academy of Dermatology and Venereology. 35(5). 1143–1151. 24 indexed citations
3.
Kahaly, George J., Marius N. Stan, Lara Frommer, et al.. (2019). A Novel Anti-Cd40 Monoclonal Antibody, Iscalimab, for Control of Graves’ Hyperthyroidism – A Proof-Of-Concept Trial. The Journal of Clinical Endocrinology & Metabolism. 2 indexed citations
4.
Espié, Pascal, Yanling He, Phillip J. Koo, et al.. (2019). First-in-human clinical trial to assess pharmacokinetics, pharmacodynamics, safety, and tolerability of iscalimab, an anti-CD40 monoclonal antibody. American Journal of Transplantation. 20(2). 463–473. 68 indexed citations
5.
Kahaly, George J., Marius N. Stan, P Gergely, et al.. (2019). OR19-6 A Novel Anti-CD40 Monoclonal Antibody, Iscalimab, Successfully Treats Graves’ Hyperthyroidism. Journal of the Endocrine Society. 3(Supplement_1). 1 indexed citations
6.
Kahaly, George J., Marius N. Stan, Lara Frommer, et al.. (2019). A Novel Anti-CD40 Monoclonal Antibody, Iscalimab, for Control of Graves Hyperthyroidism—A Proof-of-Concept Trial. The Journal of Clinical Endocrinology & Metabolism. 105(3). 696–704. 69 indexed citations
7.
Espié, Pascal, Peter Ulrich, Denise Sickert, et al.. (2018). Characterization of the in vitro and in vivo properties of CFZ533, a blocking and non-depleting anti-CD40 monoclonal antibody. American Journal of Transplantation. 18(12). 2895–2904. 74 indexed citations
8.
Ulrich, Peter, Thierry Flandre, Pascal Espié, et al.. (2018). Nonclinical Safety Assessment of CFZ533, a Fc-Silent Anti-CD40 Antibody, in Cynomolgus Monkeys. Toxicological Sciences. 166(1). 192–202. 14 indexed citations
9.
10.
11.
Espié, Pascal, et al.. (2009). Physiologically based pharmacokinetics (PBPK). Drug Metabolism Reviews. 41(3). 391–407. 98 indexed citations
12.
Nicolas, Jean‐Marie, Pascal Espié, & Mathiéu Molimard. (2009). Gender and interindividual variability in pharmacokinetics. Drug Metabolism Reviews. 41(3). 408–421. 75 indexed citations
13.
Benedetti, M. Strolin, et al.. (2007). Stereoselective renal tubular secretion of levocetirizine and dextrocetirizine, the two enantiomers of the H1‐antihistamine cetirizine. Fundamental and Clinical Pharmacology. 22(1). 19–23. 19 indexed citations
14.
Sargentini‐Maier, Maria Laura, Pascal Espié, Alain Coquette, & Armel Stockis. (2007). Pharmacokinetics and Metabolism of 14C-Brivaracetam, a Novel SV2A Ligand, in Healthy Subjects. Drug Metabolism and Disposition. 36(1). 36–45. 100 indexed citations
15.
Canal, M., Pascal Espié, & Jean‐Paul Thénot. (2002). Amisulpride: Metabolic and pharmacokinetic profile after 14C intravenous administration. European Neuropsychopharmacology. 12. 310–310. 7 indexed citations
16.
Rigoulet, Michel, Anne Devin, Pascal Espié, et al.. (1998). Flux-force relationships in intact cells: a helpful tool for understanding the mechanism of oxidative phosphorylation alterations?. Biochimica et Biophysica Acta (BBA) - Bioenergetics. 1365(1-2). 117–124. 10 indexed citations
17.
Leverve, Xavier, Brigitte Sibille, Anne Devin, et al.. (1998). Oxidative phosphorylation in intact hepatocytes: Quantitative characterization of the mechanisms of change in efficiency and cellular consequences. Molecular and Cellular Biochemistry. 184(1-2). 53–65. 15 indexed citations
18.
Devin, Anne, Pascal Espié, Bernard Guérin, & Michel Rigoulet. (1998). Energetics of swelling in isolated hepatocytes: A comprehensive study. Molecular and Cellular Biochemistry. 184(1-2). 107–121. 13 indexed citations
19.
Espié, Pascal, Anne Devin, Bernard Guérin, & Michel Rigoulet. (1997). Energetics of Isolated Hepatocyte Swelling Induced by Sodium Co-transported Amino Acids. Journal of Bioenergetics and Biomembranes. 29(6). 591–601. 6 indexed citations
20.
Espié, Pascal, Bernard Guérin, & Michel Rigoulet. (1995). On isolated hepatocytes mitochondrial swelling induced in hypoosmotic medium does not affect the respiration rate. Biochimica et Biophysica Acta (BBA) - Bioenergetics. 1230(3). 139–146. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kyoko Matsuguma Breakdown of academic impact, for papers by Himanshu Naik Breakdown of academic impact, for papers by Haiqing Dai Breakdown of academic impact, for papers by Christodoulos Flordellis Breakdown of academic impact, for papers by Megan Kane Breakdown of academic impact, for papers by Tomoaki Higuchi Breakdown of academic impact, for papers by Michael Heathman Breakdown of academic impact, for papers by Kevin Dykstra Breakdown of academic impact, for papers by Gordon Loewen
Rankless by CCL
2026